Last reviewed · How we verify
MAROPITANT
At a glance
| Generic name | MAROPITANT |
|---|---|
| Modality | Small molecule |
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
Approved indications
Common side effects
- Hypersalivation
- Vomiting
- Drowsiness/Lethargy/Apathy
- Hypersalivation
- Vomiting
- Diarrhea
- Anxiety
- Trembling/Tremors
- Inappetence
- Anorexia
- Otitis/Otorrhea
- Muscle Tremors
Serious adverse events
- Death during study
- Euthanized during study
- Hematochezia/bloody stool
- Convulsion
- Allergic reactions
- Weight loss
- Ataxia
- Corneal edema
- Enlarged lymph nodes
- Ineffectiveness
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MAROPITANT CI brief — competitive landscape report
- MAROPITANT updates RSS · CI watch RSS